These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 13679649)

  • 1. Inherited abnormalities in the protein C activation pathway.
    España F; Medina P; Navarro S; Estellés A; Aznar J
    Pathophysiol Haemost Thromb; 2002; 32(5-6):241-4. PubMed ID: 13679649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the endothelial protein C receptor gene and thrombophilia.
    Medina P; Navarro S; Estellés A; España F
    Thromb Haemost; 2007 Sep; 98(3):564-9. PubMed ID: 17849044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
    Dahlbäck B; Villoutreix BO
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
    Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
    Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulin-mediated catabolism of protein C by pleural mesothelial and vascular endothelial cells.
    Iakhiaev AV; Rezaie AR; Idell S
    Thromb Haemost; 2007 Sep; 98(3):627-34. PubMed ID: 17849052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential co-immobilization of thrombomodulin and endothelial protein C receptor on polyurethane: activation of protein C.
    Kador KE; Mamedov TG; Schneider M; Subramanian A
    Acta Biomater; 2011 Jun; 7(6):2508-17. PubMed ID: 21414427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene targeting in hemostasis: protein C.
    Castellino FJ
    Front Biosci; 2001 Jul; 6():D807-19. PubMed ID: 11438441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser252Asn Mutation Introduces a New N-Linked Glycosylation Site and Causes Type IIb Protein C Deficiency.
    Zhou S; Wu X; Song Y; Li L; Shi C; Lai Z; Ding Q; Wu W; Dai J; Wang X; Lu Y
    Thromb Haemost; 2024 May; 124(5):459-470. PubMed ID: 38011863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Gly197 in the structure and function of protein C.
    Lu Y; Biswas I; Villoutreix BO; Rezaie AR
    Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129892. PubMed ID: 33722640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
    Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
    Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protein C pathway.
    Esmon CT
    Chest; 2003 Sep; 124(3 Suppl):26S-32S. PubMed ID: 12970121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mice harboring a variant of EPCR with impaired ability to bind protein C: novel role of EPCR in hematopoiesis.
    Pepler L; Yu P; Dwivedi DJ; Trigatti BL; Liaw PC
    Blood; 2015 Jul; 126(5):673-82. PubMed ID: 26045607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin.
    Starr ME; Ueda J; Takahashi H; Weiler H; Esmon CT; Evers BM; Saito H
    Blood; 2010 Jun; 115(23):4886-93. PubMed ID: 20348393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of expression of the protein C pathway components in LPS-induced endotoxemia--implication for sepsis.
    Hayashi T; Suzuki K
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(1):2-9. PubMed ID: 25567340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
    Knobe KE; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix BO
    Proteins; 1999 May; 35(2):218-34. PubMed ID: 10223294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of endothelium with the chemotherapy agent vincristine affects activated protein C generation to a greater degree in newborn plasma than in adult plasma.
    Mewhort-Buist TA; Liaw PC; Patel S; Atkinson HM; Berry LR; Chan AK
    Thromb Res; 2008; 122(3):418-26. PubMed ID: 18206217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.